| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0003 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.001 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |